Savior LLC’s Pfizer PFE Stock Holding History

Savior LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-154	Closed	-$7K	–	202
2021 Q3	$7K	Sell	154 -1,524	-91%	-$67.5K	0.01%	119
2021 Q2	$66K	Sell	1,678 -178	-10%	-$6.92K	0.06%	118
2021 Q1	$67K	Sell	1,856 -15,904	-90%	-$565K	0.07%	110
2020 Q4	$654K	Sell	17,760 -1,294	-7%	-$47.5K	0.52%	20
2020 Q3	$663K	Buy	19,054 +4	+0%	+$140	0.78%	16
2020 Q2	$591K	Sell	19,050 -236	-1%	-$8.02K	0.75%	18
2020 Q1	$597K	Sell	19,286 -285	-1%	-$9.71K	0.7%	22
2019 Q4	$727K	Buy	+19,571	New	+$697K	0.97%	25

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Savior LLC's PFE Position: Q4 2021 in Review

Savior LLC sold out of Pfizer (PFE) in Q4 2021, closing a stake of 154 shares — an estimated $7K sold.

Savior LLC first reported a position in PFE in Q4 2019 and held it in 8 quarters. The position peaked at $727K in Q4 2019. 3,263 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

Savior LLC reported no remaining Pfizer position as of Q4 2021 after selling out during the quarter.
Savior LLC sold 154 Pfizer shares in Q4 2021, an estimated $7K.
Savior LLC first reported a position in Pfizer in Q4 2019 and held it in 8 quarters.
Savior LLC's Pfizer position peaked at $727K in Q4 2019.
3,263 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on Savior LLC's 13F filing for Q4 2021, filed 3 Feb 2022.